首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1336762

全球近距离放射治疗市场 - 2023-2030

Global Brachytherapy Market - 2023-2030

出版日期: 2023年08月22日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球近距离放射治疗市场在 2022 年达到 8 亿美元，预计到 2030 年将达到 15 亿美元，2023-2030 年预测期间年复合成长率为 8.1%。

近距离放射治疗使用密封在种子、颗粒、线或胶囊内的放射性材料，通过针或导管植入体内。该源发出的辐射会损害附近癌细胞的 DNA。近距离放射治疗最常用于治疗前列腺癌。

它还可用于妇科癌症，如宫颈癌和子宫内膜癌以及乳腺癌。近距离放射治疗还可用于其他癌症，包括肺癌、直肠癌、眼癌和皮肤癌。此外，癌症患病率的增加可以扩大近距离放射治疗市场规模。

由于美国和加拿大等国家技术进步的大幅提升，北美地区的市场需求增加。 Perspective Therapeutics、Theragenics、Eckert & Ziegler、Civco Medical Solutions 等重要参与者正在市场上积极运营。

动力学

前列腺癌发病率不断上升可促进市场增长

前列腺癌发病率的增加可以促进市场的增长。例如，据美国癌症协会估计，2023 年美国将新增约 288,300 例前列腺癌病例，并估计约 34,700 人死于前列腺癌。

老年男性和非西班牙裔黑人男性更容易患前列腺癌。每 10 例中约有 6 例是在 65 岁或以上的男性中确诊的，在 40 岁以下的男性中很少见。男性首次诊断时的平均年龄约为 66 岁。近距离放射治疗程序用于将放射性粒子（颗粒）植入前列腺以杀死前列腺癌细胞。

种子可能会发出大量或少量的辐射。许多前列腺癌患者需要近距离放射治疗。因此，上述因素表明前列腺癌的增加可以促进市场增长。

乳腺癌病例数的增加可以促进市场增长

乳腺癌病例数的增加可以加速市场的增长。例如，根据CDC的数据，在美国，每年诊断出的乳腺癌病例约为264,000例女性，约2,400例男性。美国每年约有 42,000 名女性和 500 名男性死于乳腺癌。黑人女性乳腺癌死亡率高于白人女性。

对乳腺癌患者进行间质近距离放射治疗。将几根称为导管的小空心管插入必须切除的癌症部位周围的乳房中，并保留几天。每天将放射性颗粒插入导管一小段时间，然后取出。因此，上述因素表明市场增长速度加快。

与治疗相关的副作用可能会降低市场增长

近距离放射治疗的副作用包括放射治疗部位肿胀、瘀伤、出血或疼痛和不适。用于妇科癌症或前列腺癌的近距离放射治疗可能会导致短期泌尿系统症状，包括尿失禁或排尿疼痛。

这些癌症的近距离放射治疗还会导致腹泻、便秘和直肠出血。前列腺近距离放射治疗有时会导致勃起功能障碍。上述因素可能会抑制市场的增长。

Overview

The Global Brachytherapy Market reachedUS$ 0.8 Billion in 2022 and is expected to reach US$ 1.5 Billion by 2030, growing with a CAGR of 8.1%during the forecast period 2023-2030.

Brachytherapy treatment uses radioactive material sealed inside a seed, pellet, wire, or capsule implanted in the body using a needle or catheter. The radiation given off by this source damages the DNA of nearby cancer cells. Brachytherapy is most commonly used to treat prostate cancer.

It also can be used for gynecologic cancers such as cervical cancer and uterine (endometrial) cancer, as well as breast cancer. Brachytherapy can also be utilized in others cancers including lung cancer, rectal cancer, eye cancer, and skin cancer. Furthermore, the increase in the prevalence of cancer can elevate the brachytherapy market size.

Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market experience increased demand from North American regions. Significantkey players like Perspective Therapeutics, Theragenics, Eckert & Ziegler, Civco Medical Solutions, and others are actively operating in the market.

Dynamics

The Growing Incidence of Prostate Cancer can Elevate the Market Growth

The increase in the incidence of prostate cancer can elevate the growth of the market. For instance, according to the American Cancer Society about 288,300 new cases of prostate cancer are estimated in the United States in 2023 and around 34,700 deaths are estimated from prostate cancer.

Prostate cancer is more likely to develop in older men and in non-hispanic black men. About 6 cases in 10 are diagnosed in men 65 or older, and it is rare in men under 40. The average age of men when they are first diagnosed is about 66 years. Brachytherapy procedure is used to implant radioactive seeds (pellets) into the prostate gland to kill prostate cancer cells.

The seeds may give off high or low amounts of radiation. Numerous patients with prostate cancer require brachytherapy. Thus, above mentioned factors demonstrate that an increase in prostate cancer can elevate market growth.

Rise in the Number of Breast Cancer Cases can Boost the Market Growth

An increase in the number of breast cancer cases can accelerate the growth of the market.For instance, according to CDC, each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. About 42,000 women and 500 men in the U.S. die each year from breast cancer. Black women have a higher rate of death from breast cancer than white women.

Interstitial brachytherapy is performed on breast cancer patients. Several small, hollow tubes called catheters are inserted into the breast around the area at the site of the cancer that has to be removed and are left in place for several days. Radioactive pellets are inserted into the catheters for short periods of time each day and then removed. Thus, these aforementioned factors shows the rise in the market growth.

Side Effects Associated with the Treatment can Decline the Market Growth

Side effects of brachytherapy can include swelling, bruising, bleeding, or pain and discomfort at the spot where the radiation was delivered. Brachytherapy used for gynecologic or prostate cancer can lead to short-term urinary symptoms, including incontinence or pain in urination.

Brachytherapy for these cancers can also lead to diarrhea, constipation, and rectal bleeding. Prostate brachytherapy can occasionally cause erectile dysfunction. These above mentioned factors may restrain the market growth.

Segment Analysis

The global brachytherapy market is segmented based on type, indication type, end-user and region.

High Dose Rate Brachytherapy SegmentAccounted for Approximately 39.6% of the Brachytherapy Market Share

High dose rate brachytherapy segment is expected to hold a significant position in the brachytherapy market share. In high dose-rate brachytherapy, the tumour is exposed to a high dosage of radiation but the surrounding organs are greatly spared. Radiation that is administered at a high dose-rate or at a high dose per fraction is known to be particularly sensitive to prostate cancer.

Lower toxicity than with low dosage-rate implants is achieved through quick administration and good dose conformity. Several researches have suggested that the high or intermediate risk patients who are suitable should be provided with high dose rate brachytherapy (HDR) in combination with external beam radiotherapy since it has a greater rate of cancer control than external beam alone.

A single 15 Gy HDR in conjunction with 40-50 Gy external beam radiation yields a disease-free survival rate of over 90% for moderate risk and 80% for high risk, despite the fact that different doses and fractionations have been employed. Thus, the rising research studies by the researchers are expected to raise the growth of the segment.

Geographical Penetration

North America Accounted for Approximately 42.1% of the Market Share in 2022.

North America is expected to hold a significant position in the brachytherapy market share. The increase in technological advancements in healthcare and the agreements by the companies can elevate the growth of the market in this region. For instance, on July 23, 2021, Elekta (EKTA-B.ST) announced that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron brachytherapy afterloader systems, including service agreements.

The cancer treatment devices will allow GenesisCare to continue to invest in the latest world-class technology while providing access to high-quality care to their patients throughout their U.S. centers. GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide, and Elekta is delighted to play a vital partnering role in achieving this mission. Thus, an increase in the strategic initiatives by the key players can elevate the growth of the market.

Competitive Landscape

The major global players in the brachytherapy market include Perspective Therapeutics, Theragenics, Eckert & Ziegler, Civco Medical Solutions, Mirion Technologies, Elekta AB, IsoAid, Varian Medical Systems, Inc., Prowess Inc., RaySearch Laboratories among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant influence on the brachytherapy market, posing unprecedented challenges to many countries. The delay in the diagnosis of cancers and also the delay in the treatment procedures have created a negative impact on the growth of the market. The reduction in the advancements and investments by the key companies has created a significant decline in the growth of the market. Thus, COVID-19 has created a negative impact on the growth of the market.

By Type

High-Dose Brachytherapy
Low-Dose Brachytherapy

By Indication Type

Prostate Cancer
Gynecological Cancer
Breast Cancer
Others

By End-User

Hospitals
Ambulatory Surgery Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On July 14, 2023, BEBIG Medical, a global provider of high-quality radiation therapy products, is pleased to announce its successful bid in the Ministry of Health (MOH) tender in Indonesia. BEBIG Medical has been awarded contracts to supply 6 units of HDR (high dose rate) brachytherapy equipment to hospitals across the country. This achievement highlights BEBIG Medical's commitment to delivering cutting-edge medical technology to support cancer treatment in Indonesia.
On April 20, 2023, Elekta announced that an estimated two million brachytherapy treatments have been delivered by healthcare providers using Flexitron high dose rate (HDR) afterloader. One site that has contributed to this treatment milestone is Amsterdam University Medical Centers (Amsterdam UMC) in the Netherlands, which acquired the 1,000th Flexitron recently manufactured at Elekta's facility in Veenendaal.
On January 5, 2023, C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. has received U.S. Food and Drug Administration (FDA) clearance for the use of C4 Imaging's Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray's Cesium-131, brachytherapy seeds.

Why Purchase the Report?

To visualize the global brachytherapy market segmentation based on type, indication type, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of brachytherapy market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available in Excel consisting of key products of all the major players.

The global brachytherapy market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Indication Type
3.3. Snippet by End-user
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Growing Incidence of Prostate Cancer
  - 4.1.1.2. Rise in the Number of Breast Cancer Cases
- 4.1.2. Restraints
  - 4.1.2.1. Side Effects Associated with the Treatment
- 4.1.3. Opportunity
  - 4.1.3.1. Advancements in Healthcare
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. High-Dose Brachytherapy
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Low-Dose Brachytherapy

8. By Indication Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 8.1.2. Market Attractiveness Index, By Indication Type
8.2. Prostate Cancer
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gynecological Cancer
8.4. Breast Cancer
8.5. Others

9. By End-user

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Perspective Therapeutics
- 12.1.1. Company Overview
- 12.1.2. ProductPortfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Theragenics
12.3. Eckert & Ziegler
12.4. Civco Medical Solutions
12.5. Mirion Technologies
12.6. Elekta AB
12.7. IsoAid
12.8. Varian Medical Systems, Inc.
12.9. Prowess Inc.
12.10. RaySearch Laboratories

LIST NOT EXHAUSTIVE